Home/Filings/4/0001415889-24-017992
4//SEC Filing

Tipirneni Praveen P. 4

Accession 0001415889-24-017992

CIK 0001681087other

Filed

Jun 23, 8:00 PM ET

Accepted

Jun 24, 4:32 PM ET

Size

11.4 KB

Accession

0001415889-24-017992

Insider Transaction Report

Form 4
Period: 2024-06-20
Transactions
  • Award

    Common Stock

    2024-06-20+3,0373,037 total
  • Award

    Stock Option (Right to Buy)

    2024-06-20+12,16612,166 total
    Exercise: $2.38Exp: 2031-06-27Common Stock (12,166 underlying)
  • Award

    Stock Option (Right to Buy)

    2024-06-20+11,76011,760 total
    Exercise: $16.80Exp: 2034-06-19Common Stock (11,760 underlying)
Footnotes (5)
  • [F1]Received in exchange for 5,682 shares of common stock of Tectonic Therapeutic, Inc., a Delaware corporation ("Tectonic"), pursuant to an Agreement and Plan of Merger dated as of January 30, 2024 (the "Merger Agreement") by and among AVROBIO, Inc., a Delaware corporation ("AVROBIO"), Tectonic and Alpine Merger Subsidiary, Inc., a direct, wholly owned subsidiary of AVROBIO (the "Merger Sub"). Under the terms of the Merger Agreement, on June 20, 2024, Merger Sub merged with and into Tectonic (the "Merger"), with Tectonic surviving the Merger as a wholly owned subsidiary of AVROBIO. Upon the closing of the Merger, each share of Tectonic common stock was converted into the right to receive 0.534419990 shares of the Issuer's common stock, after giving effect to a reverse stock split of the Issuer's common stock of 1-for-12. Subsequent to the Merger, the name of the Issuer was changed from AVROBIO, Inc. to Tectonic Therapeutic, Inc.
  • [F2]Upon the closing of the Merger, each outstanding option to purchase shares of Tectonic common stock was assumed by the Issuer and converted into an option to purchase the Issuer's common stock, on the same terms and conditions as were applicable to such Tectonic stock option prior to the Merger, as adjusted for the exchange ratio and the reverse stock split.
  • [F3]The shares subject to the option vest as to 25% of the shares on February 12, 2021 with the remainder vesting in the following 36 equal monthly installments, subject to the Reporting Person's continued service on each such vesting date
  • [F4]Received in exchange for a stock option to acquire 22,765 shares of Tectonic common stock pursuant to the Merger Agreement.
  • [F5]1/3rd of the shares subject to the option will vest on June 20, 2025, and the balance will vest in equal monthly installments thereafter over the next 24 months, subject in each case to the continuous service of the Reporting Person to the Issuer through the applicable vesting date.

Issuer

Tectonic Therapeutic, Inc.

CIK 0001681087

Entity typeother

Related Parties

1
  • filerCIK 0001779978

Filing Metadata

Form type
4
Filed
Jun 23, 8:00 PM ET
Accepted
Jun 24, 4:32 PM ET
Size
11.4 KB